Literature DB >> 17604583

Concurrent chemoradiotherapy for T4 patients with hypopharyngeal and laryngeal squamous cell carcinomas.

Goshi Nishimura1, Mamoru Tsukuda, Choichi Horiuchi, Kenichi Satake, Takafumi Yoshida, Junichi Nagao, Mariko Kawakami, Norio Kondo, Yasuhiro Arai, Takahide Taguchi, Hideki Matsuda, Yasukazu Mikami.   

Abstract

OBJECTIVES: Concurrent chemoradiotherapy (CCR) was given for the previously untreated T4 hypopharyngeal and laryngeal squamous cell carcinoma patients and the response and survival rates were evaluated. PATIENTS AND METHODS: A total of 23 patients, namely, 15 for hypopharynx and 8 for larynx were eligible. These patients were given cisplatin and 5-fluorouracil based chemotherapeutic regimens with conventional radiotherapy for a total dose of 66.6-70.2 Gy.
RESULTS: Ten out of the 15 hypopharyngeal carcinoma patients and 4 out of the 8 laryngeal carcinoma patients showed a complete response at the primary sites. The 5-year disease-specific survival rate was 59.4% in all the patients, 51.9% in the hypopharyngeal carcinoma patients, and 71.0% in the laryngeal patients. Seven out of the 12 resectable hypopharyngeal carcinoma patients and 4 out of 8 laryngeal carcinoma patients were able to do without total laryngectomy.
CONCLUSIONS: Based on these results, the survival rate in the hypopharyngeal and laryngeal T4 carcinoma patients treated by CCR seems to be satisfactory and the possibility of organ preservation for the advanced patients is indicated.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17604583     DOI: 10.1016/j.anl.2007.02.004

Source DB:  PubMed          Journal:  Auris Nasus Larynx        ISSN: 0385-8146            Impact factor:   1.863


  4 in total

1.  Efficacy and toxicity of (chemo)radiotherapy for primary subglottic cancer.

Authors:  M Hata; T Taguchi; I Koike; G Nishimura; M Takahashi; M Komatsu; D Sano; K Odagiri; Y Minagawa; T Inoue
Journal:  Strahlenther Onkol       Date:  2012-11-18       Impact factor: 3.621

2.  Long-term results of intensity-modulated radiotherapy concomitant with chemotherapy for hypopharyngeal carcinoma aimed at laryngeal preservation.

Authors:  Wen-Shan Liu; Chung-Han Hsin; Ying-Hsiang Chou; Jung-Tung Liu; Ming-Fang Wu; Szu-Wen Tseng; Jong-Kang Lee; Hsien-Chun Tseng; Tzu-Hwei Wang; Mao-Chang Su; Huei Lee
Journal:  BMC Cancer       Date:  2010-03-18       Impact factor: 4.430

3.  Overexpression of the orotate phosphoribosyl-transferase gene enhances the effect of 5-Fluorouracil in head and neck squamous cell carcinoma in vitro.

Authors:  Ryuji Yasumatsu; Torahiko Nakashima; Shizuo Komune
Journal:  J Oncol       Date:  2012-03-26       Impact factor: 4.375

Review 4.  Organ preservation strategies: Review of literature and their applicability in developing nations.

Authors:  Mitali Dandekar; Anil D'Cruz
Journal:  South Asian J Cancer       Date:  2014-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.